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The Distal-less (Dlx) homeobox transcription factors (TFs) play a prominent role in regulating multiple
facets of vertebrate biology. Though widely studied as mediators of tissue development, recent work has
uncovered a role for this TF family in modulating the vertebrate hematopoietic compartment. Pertinent
to our study, murine Dlx1-3 are expressed in an innate lymphocyte population known as natural killer
(NK) cells, and they are implicated to assume a functional role in the NK cell maturation pathway.
However, Dlx target genes are poorly understood. In Drosophila, the invertebrate Dlx ortholog Distal-less
(Dll) regulates another transcription factor called Spineless (ss), which is critical for specifying distal
antennal segments. Importantly, the vertebrate ortholog of ss is the aryl hydrocarbon receptor (AhR), a
transcription factor recently shown to be important in the regulation of a number of immune cell sub-
sets, including NK cells. Given these ﬁndings, we investigated whether Dlx TF family members might
analogously regulate AhR in an NK cell context. Our results demonstrate that Dlx3 is constitutively co-
expressed with AhR in murine and human CD127þ NK cells. Critically, we show that Dlx3 induces AhR
promoter activity by binding to a regulatory region that resides 5.5 kb upstream of the transcriptional
start site. This mechanism is functionally relevant, as Dlx3 expression in human NK cells signiﬁcantly
enhances TF activity at AhR DNA-binding elements (Xenobiotic Responsive Elements, XREs). Thus, our
study deﬁnes Dlx3 as a positive regulator of the aryl hydrocarbon receptor.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Natural killer (NK) cells are an innate lymphocyte population
in vertebrates that provide immediate defense against viral pa-
thogens and malignant cells via both cell contact-dependent and
–independent mechanisms. In humans, NK cells are generally
deﬁned as CD3-CD56þ cells, and in C57BL/6 mice, NK cells are
deﬁned as CD3-NK1.1þ cells. Found in a wide range of organs (i.e.
liver, bone marrow, spleen, lymph node, thymus, etc.), the de-
velopment of this phenotypically and functionally heterogeneous
lymphocyte population involves the sequential acquisition and
loss of various cell surface markers and transcription factors (TFs)
[reviewed in Ref. [1]]. In brief, conventional NK cells in both
humans and mice are derived from a common lymphoid pro-
genitor (CLP) cell present in the bone marrow [1]. Once com-
mitment to the NK cell lineage has occurred in an interleukin
(IL)-15-dependent manner, the early acquisition of CD56 ex-
pression on human NK cells (CD56bright) and CD27 on mouse NKB.V. This is an open access article u
4305, USA.
o).cells (CD27high) marks an immature phenotype, which is func-
tionally associated with robust cytokine secretion but not target
cell killing [1]. However, downregulated CD56 expression and
augmented CD16 expression correlates with human NK cell ma-
turation, whereas a loss of CD27 and the acquisition of CD11b
correlates with mouse NK cell maturation [1]. Furthermore, ex-
pression of T-bet, a T-box TF, is activated in immature NK cells to
facilitate their developmental stability and terminal maturation
[2–4]. In both humans and mice, these phenotypic changes are
generally associated with NK cells exhibiting a heightened ca-
pacity for target cell killing coming at the expense of cytokine
secretion. However, in addition to conventional NK cells, recent
work has begun to uncover the vast tissue-speciﬁc develop-
mental and functional heterogeneity characteristic of this lym-
phocyte population [reviewed in Ref. [5]]. Pertinent to this study,
a subset of NK cells that uniquely expresses CD127 (IL-7 receptor
α) has been previously suggested to predominately reside in the
thymus and lymph nodes where their development uniquely
depends on the TF GATA-3 [5]. Functionally, the “thymic” NK cells
behave similar to immature conventional NK cells in that they are
able to robustly secrete cytokines but fail to efﬁciently kill target
cells [5]. Altogether, characterization of the developmental andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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intense area of investigation.
The Distal-less (Dlx) homeobox TF family in vertebrates con-
sists of six members that are expressed during development ac-
cording to tissue type and spatiotemporal dynamics [6]. These
gene regulators are critical for the speciﬁcation and function of
various tissues and anatomical structures, such as the nervous
system and craniofacial skeleton [7,8]. In addition, Dlx proteins
have been attributed to regulating hematopoietic cell prolifera-
tion and survival, as well as lymphopoiesis [6,9]. Relevant to our
study, Dlx1-3 are expressed in NK cells, with Dlx3 being most
highly expressed in immature CD11blo NK cells [9]. Furthermore,
Dlx1 and Dlx3 play an important role in early NK cell develop-
ment, as persistent expression of either gene arrests NK cells in
an immature phenotype while modulating the downstream ex-
pression of TFs involved in NK cell maturation [9]. However,
characterization of Dlx target genes in vertebrates remains
incomplete.
The aryl hydrocarbon receptor (AhR) is a transcriptional reg-
ulator of the Per (period circadian protein)-Arnt (aryl hydrocarbon
receptor nuclear translocator protein)-Sim (single-minded pro-
tein) (PAS) superfamily of proteins that undergo activation in re-
sponse to numerous endogenous metabolites, dietary compounds,
and environmental contaminants/toxins [10,11]. Upon ligand
binding, AhR translocates from the cytoplasm to the nucleus
where it binds the aryl hydrocarbon receptor nuclear translocator
(ARNT) to modulate gene expression by engaging segments of
DNA known as Xenobiotic Responsive Elements (XREs). Initially
studied in the immune system as a regulator of T helper 17 (Th17)
cell and regulatory T (Treg) cell differentiation and development
[12,13], AhR has been further implicated to play a role in med-
iating the murine NK cell anti-tumor [14] and IL-10 responses [15],
and its expression and function has been described in non-con-
ventional, IL-22 producing human NK cells [16], among other
immune cell types [17]. What determines AhR gene expression in
these contexts is poorly understood.
In Drosophila, the invertebrate AhR ortholog, Spineless (ss), plays
a key role in specifying distal antennal segments during devel-
opment [18]. Critically, its expression is positively regulated by the
Dlx ortholog, Distal-less (Dll), which serves as a primary activator
of the ss antennal disc enhancer [19–21]. Thus, given these pre-
vious ﬁndings, along with what has been observed regarding the
expression of Dlx TFs and AhR in lymphocytes, we hypothesized
that Dlx proteins could similarly regulate AhR promoter activity in
the vertebrate NK cell setting. In this study, we show that Dlx3 and
AhR are abundantly co-expressed in murine and human CD127þ
NK cells. Our data further reveal that a segment of the AhR pro-
moter, 5.5 kb upstream of the transcriptional start site, is un-
iquely bound by Dlx3 to induce AhR expression. In the human NK
cell line NK-92MI, Dlx3 enhances AhR activity at XRE sequences,
thus describing a previously unidentiﬁed mechanism whereby
vertebrate Dlx3 positively regulates AhR.2. Materials and methods
2.1. Mice and human subjects
C57BL/6 mice were obtained from Jackson Laboratory (Bar Harbor,
ME, USA) and bred in facilities at Stanford University (Stanford, CA,
USA). All mice were housed in pathogen-free conditions with free
access to food and water. 6- to 8-week old mice were used for ex-
periments. Procedures performed in this study were all in accordance
with the Stanford University Institutional Animal Care and Use
Committee guidelines and with the National Institutes of Health
guide for the care and use of laboratory animals. Human bloodsamples, obtained with informed consent, were provided by the
Stanford School of Medicine Blood Center (Palo Alto, CA, USA).
2.2. Cell culture
293T human embryonic ﬁbroblast cells were grown in Dul-
becco's Modiﬁed Eagle Medium: Nutrient Mixture F-12 (DMEM/
F12; Life Technologies, Carlsbad, CA, USA) supplemented with 10%
fetal bovine serum (FBS; Life Technologies) at 37 °C in 5% CO2. The
human NK-92MI cell line was cultured in RPMI Medium (Life
Technologies) supplemented with 2 mM L-glutamine, 0.2 mM
I-inositol, 20 mM folic acid, 100 μM β-mercaptoethanol, 12.5% FBS,
and 12.5% horse serum (Stemcell Technologies, Vancouver, BC,
CAN). Culture media were renewed every 2–3 days depending on
cell density, and sub-culture was conducted when conﬂuence was
reached.
2.3. Cell sorting
Spleens and lymph nodes from C57BL/6 mice were isolated,
mechanically homogenized, and stained with PerCP-Cy5.5-anti-
mouse CD3, APC-anti-mouse NK1.1, and PE-anti-mouse CD127
antibodies (all from BD Biosciences, San Jose, CA, USA) according
to the manufacturer's protocols. Peripheral blood mononuclear
cells (PBMCs) were obtained from healthy volunteers after Ficoll
gradient centrifugation (GE Healthcare, Piscataway, NJ, USA).
Mononuclear cells were resuspended in RPMI media and stained
with PerCP-Cy5.5-anti-human CD3, APC-anti-human CD56, and
PE-anti-human CD127 antibodies (all from BD Biosciences) ac-
cording to the manufacturer’s protocols. Labeled cells were
analyzed and sorted using a FACSAria III cell sorter (BD
Biosciences).
2.4. Plasmid construction
To construct pMXs-Flag-Dlx3-IRES-EGFP, an EcoRI/XhoI frag-
ment generated by PCR ampliﬁcation of mouse and human Dlx3
from the PCR cloning vector PCR-XL-Topo (Invitrogen, Carlsbad,
CA, USA) was sub-cloned into the EcoRI/XhoI site of pMXs-Flag-
IRES-EGFP (a kind gift from Wayne Yokoyama, Washington Uni-
versity, St. Louis, MO, USA). pMXs-Flag-mDlx1 and -mDlx2 were
also constructed by sub-cloning PCR products. pEGFP-Oct4 was
constructed by sub-cloning Oct4 PCR products into pEGFP-C1
(Clontech Laboratories, Mountain View, CA, USA). Promoter re-
gions AhR-8 (5638/5403), AhR-8/9 (5638/3981) and AhR-
P (1805/375) of the AhR gene were incorporated into the XhoI/
HindIII sites of the pGL3 basic luciferase reporter (Promega, Sun-
nyvale, CA, USA) using PCR ampliﬁcation and sub-cloning to gen-
erate pGL3-basic-AhR vectors.
2.5. Quantitative real-time polymerase chain reaction (qRT-PCR)
For examining the effect of Dlx3 on AhR expression, pMXs-
Flag-hDlx3 was transfected into human NK-92MI cells with Li-
pofectamine 2000 (Invitrogen, Carlsbad, CA, USA). RNA was iso-
lated 48 h after transfection and subjected to qRT-PCR probing for
hAhR expression. For all qRT-PCR assays, total RNA was prepared
from cells with the RNeasy Mini Kit (Qiagen, Hilden, DEU) and
treated with DNase I (STEMCELL Technologies, Seattle, WA, USA)
to remove residual genomic DNA. cDNA was prepared with ran-
dom primers using the First-Strand Synthesis System (Thermo
Fisher Scientiﬁc, Waltham, MA, USA). Real-time PCR was done in
triplicate with TaqMan PCR mixture (Applied Biosystems, Foster
City, CA, USA) for 2 min at 50 °C and 10 min at 95 °C for initial
denaturing, followed by 40 cycles of 95 °C for 15 s and 60 °C for
1 min using the 7900HT Fast Real-Time PCR System (Applied
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were purchased from Applied Biosystems, Foster City, CA, USA.
The expression of genes was normalized to the housekeeping
HPRT gene. Fold changes in expression for each gene were cal-
culated as 2Δ(ΔCT) where ΔCT¼CT (target) CT (housekeeping),
and Δ(ΔCT)¼ΔCT (treated)ΔCT(control). Reaction product
purity was conﬁrmed through examination of melting curves for
a single peak.
2.6. Chromatin immunoprecipitation (ChIP) assay
To elucidate the AhR binding site for mouse Dlx3, ChIP assays
were conducted with a ChIP-IT Enzymatic Kit (Active Motif,
Carlsbad, CA, USA) according to the manufacturer’s protocol. In
brief, 293T cells were transiently transfected with pMXs-Flag-
mDlx3-IRES-EGFP and an AhR-containing bacterial artiﬁcial chro-
mosome (BAC) clone (AhR genomic clone RP23-157I22; BACPAC
Resources, Oakland, CA, USA). Cells were treated with 1% for-
maldehyde followed by glycine stop solution, collected, cen-
trifuged at 4 °C, and resuspended in lysis buffer. After an additional
30 min of lysis and 10 strokes in a dounce homogenizer, nuclei
were isolated by 10 min of centrifugation at 2400 g and re-
suspended in shearing buffer. Genomic DNA was sheared by so-
nication on ice, and after centrifugation, 10 μl of the supernatant
(containing sheared chromatin) was used as assay input. Im-
munoprecipitation was carried out overnight at 4 °C using an in-
cubation mixture containing 10 μl sheared chromatin, protein G
magnetic beads, BSA, sheared sperm DNA, and 3 μg of anti-Flag
M2 monoclonal antibody (Sigma-Aldrich, St. Louis, MO, USA). After
centrifugation, washing, and elution, samples were reverse cross-
linked and treated with ribonuclease A and proteinase K. DNA was
then puriﬁed using DNA minicolumns provided with the kit, and
PCR was performed with primers indicated in Supplementary
Table 1.
2.7. Transient transfection and luciferase reporter assay
293T cells (1105 per well) were seeded in a 6-well plate one
day prior to plasmid transfection with Lipofectamine 2000. For
the AhR promoter reporter assay, 0.1 μg of reporter plasmid
pGL3-basic-AhR was co-transfected with 0.2, 0.4 or 0.6 μg of
Dlx1, Dlx2, Dlx3 or Oct4 expression vectors, and with 0.1 μg pRL-
TK (Renilla luciferase; Promega, Madison, WI, USA). Cells were
harvested 24 h after DNA transfection and ﬁreﬂy luciferase and
Renilla luciferase activities were measured using a Dual-Lucifer-
ase Reporter Assay System (Promega, Madison, WI, USA). Fluor-
escence intensity was measured using FLUOstar OPTIMA (BMG
LABTECH, Ortenberg, DEU). Promoter activity was determined
from the ﬁreﬂy luciferase activity in each reaction, normalized
against Renilla luciferase activity. To measure the effect of Dlx3
protein on downstream AhR activity, NK-92MI cells (1105)
containing a Cignal XRE reporter construct [14] were plated onto
96-well plates and transiently transfected with variable con-
centrations of the human Dlx3 expression vector. Luciferase ac-
tivity was measured after 48 h. shRNA targeting human AhR was
obtained from Genecopoeia (Rockville, MD, USA).
2.8. Statistical analysis
Standard deviation and standard error of the mean were
calculating using Microsoft EXCEL software. Two-tailed Stu-
dent's t-test (EXCEL) was used to determine statistical differ-
ences between samples analyzed by qRT-PCR and luciferase
reporter assays. A value of Pr0.05 was considered to be
signiﬁcant.3. Results
3.1. AhR and Dlx3 are co-expressed in murine and human CD127þ
NK cells
As AhR expression has been described in human NK cells iso-
lated from lymphoid tissue [16], we examined the expression of
this TF in murine NK cells isolated from the lymph node and
spleen. Similar to what was seen with human NK cells, NK cells
(deﬁned as CD3-NK1.1þ) sorted from murine lymph nodes also
robustly expressed AhR (Fig. 1). A signiﬁcant proportion of NK cells
in murine lymph nodes express the IL-7 receptor α (CD127), and
the expression of AhR was signiﬁcantly higher in the CD127þ NK
cells compared to what was observed in the CD127- NK cell
compartment (Fig. 1B). The CD127þ NK cells have previously been
described to be of thymic origin and distinct from conventional NK
cells [22,23]. Examination of additional transcription factor ex-
pression differences between the CD127þ and CD127- NK cell
populations demonstrated a higher level of expression of Dlx3 and
lower level expression of T-bet in the CD127þ NK cells (Fig. 1B),
and no expression of Dlx1 and Dlx2 was observed in either po-
pulation (data not shown). Although the proportion of CD127þ NK
cells in the spleen is lower than what is seen in lymph node tissue
(Fig. 1A), the same patterns of AhR, Dlx3, and T-bet expression were
observed in NK cells sorted by CD127 expression from both sec-
ondary lymphoid organs (Fig. 1B and C).
To assess if the expression patterns of AhR, Dlx3, T-bet, and
CD127 also applied to human NK cells, we sorted CD3-CD56dim and
CD3-CD56bright NK cells from human peripheral blood mono-
nuclear cells (Fig. 2A). The CD3-CD56bright NK cells expressed
higher levels of CD127 (Fig. 2B), which has been previously de-
scribed [23]. These cells also expressed higher levels of AhR and
Dlx3 and lower levels of T-bet (Fig. 2B), consistent with what was
observed in the murine CD127þ NK cells (Fig. 1). We also sorted
CD3-CD56þCD127þ and CD3-CD56þCD127- NK cells from human
peripheral blood mononuclear cells (Fig. 2A), and the expression
patterns of Dlx3, AhR and T-bet were again consistent with what
was seen in murine NK cells, as Dlx3 and AhR were more robustly
expressed in the human CD127þ NK cell compartment (Fig. 2C).
3.2. Dlx3 binds the AhR promoter
Because Distal-less, the invertebrate ortholog of the Dlx TF fa-
mily, induces expression of the AhR ortholog Spineless in Droso-
phila [19–21], we hypothesized that the co-expression of Dlx3 and
AhR observed in NK cells may reﬂect the regulation of AhR ex-
pression by Dlx3 protein. To investigate the ability of Dlx3 to
regulate AhR expression, a BAC containing the AhR promoter re-
gion and a Flag-tagged Dlx3 expression construct were co-trans-
fected into 293T cells, and chromatin immunoprecipitation (ChIP)
of bound genomic DNA fragments using anti-Flag antibodies was
then analyzed by PCR. Oligonucleotide primers spanning the 13 kb
region upstream of the AhR transcription start site (Supplementary
Table 1) were used to identify a sub-region to which Dlx3 bound.
The DNA segment designated as AhR-8, 5638 to 5403 bp of the
ATG start site, was uniquely enriched in precipitated DNA (Fig. 3A),
thus indicating that Dlx3 is able to bind this region. Indeed, our
analysis of AhR-8 identiﬁed 7 potential Dlx3 binding sites (data
not shown). To conﬁrm that Dlx3 binds this portion of the AhR
promotor, we cloned the sequence spanning position 5638 to
5403 bp into a luciferase reporter construct. This reporter con-
struct was then co-transfected with a Dlx3 expression vector into
293T cells. In agreement with our ChIP data, Dlx3 was able to in-
duce AhR-8-controlled luciferase activity in a dose-dependent
manner (Fig. 3B). This effect was speciﬁc to the Dlx3 family
member since Dlx1 and Dlx2 were not able to induce expression of
Fig. 1. Dlx3 and AhR are co-expressed in mouse CD127þ NK cells. (A) CD3-NK1.1þCD127þ and CD3-NK1.1þCD127- NK cells were sorted by FACS (as indicated by red gates)
from the spleen and lymph node of wild-type C57BL/6 mice. (B-C) The expression of Dlx3, AhR, CD127, and T-bet (normalized to HPRT expression) were assessed by qRT-PCR
in CD127þ and CD127- spleen (B) and lymph node (C) NK cells. (*Pr0.05 and **Pr0.01; n¼3; experiments were performed three times).
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(Fig. 3B). Dlx3 binding activity in this region was further sub-
stantiated by performing the reporter assay again, but with a lar-
ger segment of the promoter (AhR-8/9), which included the
5638 to 3981 bp region upstream of the transcription start
site. Indeed, Dlx3 induced luciferase expression when controlled
by the AhR-8/9 region (Fig. 3B), and Dlx3 activity was speciﬁc to
this segment of DNA as the TF was not able to induce luciferase
activity when controlled by a region of the promoter more prox-
imal (1805 to 375 bp) relative to the ATG start site (Fig. 3C).
3.3. Dlx3 promotes AhR expression and function in human NK cells
To provide functional evidence for Dlx3 as a regulator of AhR,
we took advantage of the well-characterized human NK cell line
NK-92MI. These cells were transfected with an expression vector
encoding human Dlx3. As expected, after 48 h, NK-92MI cellsreceiving this construct highly expressed hDlx3 whereas those
receiving a control vector did not (Fig. 4A). Importantly, persistent
hDlx3 expression was accompanied by an increase in hAhR ex-
pression (Fig. 4A), thus supporting our luciferase reporter data
(Fig. 3), which indicated that Dlx3 positively regulates AhR gene
expression. To then show that this Dlx3-mediated induction of AhR
was accompanied by increased AhR activity, we co-transfected NK-
92MI cells with our hDlx3 expression vector and a Cignal XRE
reporter construct, which has been previously described [14]. As
AhR modulates downstream gene expression via engagement of
XRE DNA sequences, we hypothesized that increases in Dlx3
would elicit greater XRE reporter activity due to augmented AhR
expression. Indeed, persistent hDlx3 expression led to a dose-de-
pendent increase in XRE reporter activity (Fig. 4B)—an effect at-
tributable to changes in AhR expression (Fig. 4C)—thus providing
further evidence that Dlx3 functionally enhances AhR.
Fig. 2. Dlx3 and AhR are co-expressed in CD56bright and CD127þ human NK cells. (A) CD56bright and CD56dimCD3- human NK cells were sorted by FACS from peripheral blood
mononuclear cells isolated over a Ficoll gradient. Red boxes indicate the sorting gates. FACS proﬁling of CD127 is shown for each sorting gate (i.e. CD56bright and CD56dim
cells). FSC¼ forward scatter. (B-C) The expression of Dlx3, AhR, CD127, and T-bet (normalized to HPRT expression) was assessed by qRT-PCR in human peripheral blood NK
cells sorted by FACS into CD3-CD56dim and CD3-CD56bright subsets (B), and CD3-CD56þCD127þ and CD3-CD56þCD127- subsets (C) (*Pr0.05 and **Pr0.01; n¼3; ex-
periments were performed three times). Note, CD56þ includes CD56bright and CD56dim cells.
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The transcriptional regulator Distal-less (Dll) was ﬁrst identiﬁed
in Drosophila as a single gene that is critical for proximodistal
patterning in limb development. During speciﬁcation of distal
antennal segments, Dll serves as a primary inducer of Spineless (ss),
the invertebrate ortholog of AhR [19–21]. The Distal-less (Dlx) TF
family members in vertebrates similarly function to mediate de-
velopment of the skin, limbs, nervous system, and craniofacial
skeleton [24], though recent evidence has implicated an additional
role for these proteins in regulating immune development and
hematopoietic function. As high expression of murine Dlx1-3 hasbeen described in the immature conventional NK cell compart-
ment [9], and because AhR expression has been observed in im-
mature NK cells isolated from human lymphoid tissue [16,25], we
wondered whether Dlx TFs might promote AhR activity in a ver-
tebrate NK cell setting, akin to the regulation observed in
Drosophila.
Indeed, the results of our study suggest a mechanism whereby
Dlx3 acts as a positive regulator of AhR expression. Speciﬁcally, we
observed robust co-expression of Dlx3—but not Dlx1 or Dlx2—and
AhR in murine and human CD127þ NK cells, which are known to
exhibit the phenotypic characteristics of immature conventional
NK cells as deﬁned by low CD11b (Mac-1) expression [26]. To
Fig. 3. Dlx3 binds and activates the AhR promoter. (A) A Flag-mDlx3 (mouse Dlx3) expression vector and AhR-containing BAC clone were co-transfected into 293 T cells and
mDlx3 was immunoprecipitated with a speciﬁc anti-Flag antibody. After isolation of genomic DNA fragments bound to mDlx3, PCR using oligonucleotide primers speciﬁc to
13 AhR promoter regions, spanning 13 kb upstream of the transcription start site, was performed. (B-C) A transient-transfection analysis was performed with AhR-8 (5638/
5403) and AhR-8/9 (5638/3981) luciferase reporters transfected into 29T cells in the presence of mouse Dlx1, mouse Dlx2 or mouse Dlx3 expression vectors, or a
control mouse Oct4 expression vector (B). (C) Activity of an AhR-P (1805/375) luciferase reporter, or control luciferase reporters, was analyzed in 293T cells co-trans-
fected with a human Dlx3 (hDlx3) or mDlx3 expression vector. “mock”¼no reporter construct transfected. “pGL3-P”¼the “pGL3-Promoter” construct, which contains the
SV40 promoter. “pGL3-B”¼the “pGL3-Basic” construct, which lacks any promoter or enhancer. “pGL3-AhR-P”¼the AhR-P segment of the AhR promoter (1805 to 375
upstream of the ATG start site) cloned into the pGL3-Basic vector.
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activity, we co-transfected 293T cells with a Dlx3 expression vec-
tor and an AhR-containing BAC. Using ChIP analysis, we found that
Dlx3 protein uniquely bound to a DNA segment 5638 to 5403
bp of the AhR transcriptional start site. We used luciferase reporter
assays to conﬁrm this observation. Finally, to provide evidence for
this mechanism in the context of NK cell biology, we transfected
NK-92MI cells with a human Dlx3 expression vector and subse-
quently observed both augmented AhR expression and increased
reporter activity (regulated by XRE DNA sequences) indicating an
increase in AhR activity. Because Dll has been shown to interactcooperatively with Homothorax and Extradenticle (orthologs of
vertebrate Meis1 and Pbx1, respectively) in binding to the Spineless
promoter [21], we examined the AhR promoter region but were
unable to ﬁnd Meis1 and Pbx consensus binding sites [27,28] near
the Dlx3 binding site. Nevertheless, we did check to see if Meis1
and Pbx are expressed in murine NK cells, and we found that they
are expressed (Supplementary Fig. 1).
Exploration into the physiologic relevance of Dlx3-regulated
AhR expression is complicated by the fact that Dlx3 deﬁciency in
mice causes early embryonic lethality. However, as mice homo-
zygous for targeted AhRmutation exhibit moderate developmental
Fig. 4. Dlx3 induces AhR activity in NK cells. (A) Total RNAwas isolated 48 h after transfection of NK-92MI cells with a hDlx3 expression vector and was subjected to qRT-PCR
probing for hDlx3 and hAhR expression (*Pr0.05). (B) NK-92MI cells stably transfected with a luciferase reporter vector containing AhR binding sites (XRE sequences) in its
promoter were transiently transfected with varying concentrations of an hDlx3 expression vector. Luciferase activity was measured after 48 h to assess for AhR activity
(**Pr0.01; n¼3; experiments performed at least three times). (C) NK-92MI cells, stably expressing the XRE-luciferase reporter construct, were transfected with human Dlx3,
shRNA targeting AhR, or both, and luciferase activity was measured after 48 h to assess for AhR activity (*Pr0.05; n¼3; experiment performed three times).
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AhR is not a critical Dlx3 target during early vertebrate develop-
ment. However, it is interesting that loss of AhR has been shown to
signiﬁcantly reduce the number of certain hematopoietic cell
types in post-natal mice, most notably type 3 innate lymphoid
cells (ILC3) [31,32], which—for human ILC3 cells—have been
shown to undergo differentiation to NK cells upon AhR silencing
[25]. Furthermore, because AhR is induced upon NK cell exposure
to cytokines such as IL-2 and can modulate NK cell activity [14],
AhR appears to serve a post-developmental homeostatic and/or
functional role for regulating the NK cell response. This is intri-
guing as robust Dlx3 and AhR co-expression has been noted in NK
cell populations that are specialized for cytokine secretion and
immunomodulation, for example, CD127þ NK cells (Figs. 1 and 2),
CD27þCD11b- immature conventional NK cells in mice [un-
published data], and immature CD56bright NK cells in humans
(Fig. 2). Furthermore, AhR has been implicated to regulate both the
NK cell killing and cytokine responses in mice [14,15]. As a result,
experiments that make use of NK cell-speciﬁc Dlx3 ablation will be
useful for exploring the functional relevance of this mechanism in
mediating tumor control and viral immunity, two parameters of
immune function that are prominently affected by NK cell activity.
In addition, given the emerging role of AhR in regulating
multiple immune pathways, it will be interesting to explore the
relevance of Dlx3-AhR crosstalk in other hematopoietic cell types.
B and T lymphopoiesis has been previously linked to Dlx TF
function [9], though a speciﬁc role for Dlx3 in controlling the
hematopoietic compartment has yet to be described. Experiments
using mice derived from Dlx3-/- embryonic stem cells com-
plemented with Rag-/-γc-/- mouse blastocysts—which do not de-
velop T, B, and NK cells—will allow for the examination of AhR
expression differences throughout these lymphocyte populations,
as compared to Dlx3-immunosufﬁcient mice. Thus, our elucidation
of a previously undeﬁned mechanism, whereby Dlx3 induces AhR
promoter activity, is likely to assume a role in regulating down-
stream gene expression throughout many facets of vertebrate
biology and immunology.Acknowledgements
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